These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 24947242)
1. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation. Liu CC; Lin JH; Hsu TW; Su K; Li AF; Hsu HS; Hung SC Int J Cancer; 2015 Feb; 136(3):547-59. PubMed ID: 24947242 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163 [TBL] [Abstract][Full Text] [Related]
3. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257 [TBL] [Abstract][Full Text] [Related]
4. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line. Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397 [TBL] [Abstract][Full Text] [Related]
5. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351 [TBL] [Abstract][Full Text] [Related]
7. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells. Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503 [TBL] [Abstract][Full Text] [Related]
8. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111 [TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway. Wu L; Guo L; Liang Y; Liu X; Jiang L; Wang L Oncol Rep; 2015 Dec; 34(6):3311-7. PubMed ID: 26397387 [TBL] [Abstract][Full Text] [Related]
10. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463 [TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. Lin C; Wang L; Wang H; Yang L; Guo H; Wang X J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Cheng JC; Auersperg N; Leung PC Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913 [TBL] [Abstract][Full Text] [Related]
13. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Chen C; Chang YC; Liu CL; Chang KJ; Guo IC Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
15. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b. Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267 [TBL] [Abstract][Full Text] [Related]
17. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer]. Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908 [TBL] [Abstract][Full Text] [Related]
18. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells. Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080 [TBL] [Abstract][Full Text] [Related]
19. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop. Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676 [TBL] [Abstract][Full Text] [Related]
20. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway. Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]